Drug Target Review – Issue #4 2015

Posted: 3 December 2015 | Drug Target Review | 3 comments

Included in this issue: Biomarkers, Mass Spectrometry, Target Validation, Drug Development, Personalised Medicines, Next-Generation Sequencing, Protein Expression, Companion Diagnostics, and much more…

DTR Issue 4 2015

In Issue #4 2015 of Drug Target Review:

  • FOREWORD: Avoid falling off a ladder and into the dock
    Jacob Gifford Head, Thomas More Chambers
  • BIOMARKERS: Biomarkers as molecular footprints for cancer therapy: current perspectives and promises
    Mahfoozur Rahman and Vikas Kumar, Sam Higginbottom, Institute of Agriculture, Technology & Sciences, Sarwar Beg, Panjab University, and Firoz Anwar, King Abdulaziz University
    With articles from Michelle M. Hill, University of Queensland, and Nicola Burgess-Brown, Rod Chalk, Claire Strain-Damerell and Pravin Mahajan, Structural Genomics Consortium
  • TARGET VALIDATION: The challenges associated with ‘de-risking’ early-stage therapeutic targets
    Ahmad Kamal, Debbie Taylor, Tim Chapman and Catherine Kettleborough, MRC Technology’s Centre for Therapeutics Discovery
  • DRUG DEVELOPMENT: Enabling new targets by integrated lead discovery
    Ulrich Schopfer and Sylvain Cottens, Novartis
  • PERSONALISED MEDICINES: 3D printing – A new era for personalised medicines?
    Dr Simon Gaisford, University College London School of Pharmacy
  • NEXT-GENERATION SEQUENCING: Next-generation transcriptomic analysis in cancer vascular research
    Joseph W. Wragg and Roy Bicknell, University of Birmingham
  • PROTEIN EXPRESSION: The growing potential of plant-made monoclonal antibodies
    Qiang “Shawn” Chen and Huafang Lai, Arizona State University
  • COMPANION DIAGNOSTICS: Challenges in the development of pharmacist-based point-of-care tests
    Allison M. Dering-Anderson and Meagan Doyle, University of Nebraska College of Pharmacy

Issue #4 2015 is restricted - login or subscribe free to access

Screening the future innovations in drug discoveryThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here


3 responses to “Drug Target Review – Issue #4 2015”

  1. Lucio Annunziato says:

    It appears an attractive journal

  2. JinJye says:

    Arouse interest for this journal

  3. Albert Giovenella says:

    Nice work to you and your team for putting together such interesting topics.

Leave a Reply

Your email address will not be published. Required fields are marked *